About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, December 7th, 2017

The QualityStocks
Daily Stock List


Endonovo Therapeutics, Inc. (ENDV)

SeeThruEquityResearch, DSR News, Planet Penny Stocks, SecretStockPromo, StockOnion, BestDamnPennyStocks, Penny Picks, Buzz Stocks, Damn Good Penny Picks, Penny Pick Finders, Innovative Marketing, HEROSTOCKS, Stock Brain, SmallCapVoice, PennyStockProphet, Penny Stock Newsletter, PHUB News, Stock Commander, TheNextBigTrade, PREPUMP STOCKS, and OTC Markets Group reported on Endonovo Therapeutics, Inc. (ENDV), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Endonovo Therapeutics, Inc. is a biotechnology company based in Woodland Hills, California. It is a leading developer of bioelectronic-applications in cell therapies and non-invasive electroceuticals. Endonovo’s initial concentration is on the treatment of acute and chronic inflammatory conditions of the liver employing its proprietary Immunotronics™ platform and the treatment of Graft-Versus-Host Disease using its ex vivo expanded and enhanced stem cells. Endonovo Therapeutics is centering its efforts on inflammatory conditions in vital organs.

The Company’s Immunotronics™ platform is a non-invasive, non-implantable, bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation, cell death, and the promotion of regeneration. Its Cytotronics™ platform provides for a method of expanding and manipulating cells utilizing simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies.

The basis for Endonovo’s TVEMF technology was created at NASA in combination with the development of cell therapies to treat injuries and diseases that astronauts might encounter during long term manned missions in space. The purpose of the Company’s Cytotronics™ platform is to create optimized cell-based therapies with more therapeutic potential than the un-modulated cells presently being used in regenerative medicine.

Endonovo Therapeutics is in the pre-clinical phase of evaluating its proprietary Immunotronic technology in the treatment of chronic and acute inflammatory conditions in the liver. This includes fulminant liver failure.

The Company is developing a next-generation, off-the-shelf treatment for Graft-Versus-Host Disease (GVHD) using Cytotronics™ expanded and ex vivo enhanced stem cells from the human umbilical cord. Endonovo is expanding its liver disease research program and its Cytotronics™ platform to create a high-fidelity drug development and toxicology testing platform.

Endonovo Therapeutics is starting a pre-clinical study at a contract research organization to assess the therapeutic potential of its Immunotronics™ platform in the treatment of critical limb ischemia (CLI). This pre-clinical study will evaluate the effect of the Company’s non-invasive electroceutical technology on limb function, ischemia damage, as well as blood flow. This includes the formation of new blood vessels (angiogenesis).

Moreover, Endonovo is starting a pre-clinical study at a contract research organization to assess the therapeutic potential of its Immunotronics™ platform in preventing and reversing inflammation in Non-Alcoholic Steatohepatitis (NASH). In addition, it is starting a pre-clinical study at a contract research organization to assess the therapeutic potential of its Immunotronics™ platform in preventing and reversing inflammation and fibrosis in kidney disease.

Recently, Endonovo Therapeutics reported that it completed a study to evaluate the potential efficacy of its Immunotronics™ platform in a well-established preclinical model of heart failure (post-MI remodeling). With these positive results, Endonovo continues to advance the development of its pipeline of non-invasive electroceuticals targeting vascular diseases and inflammatory conditions in vital organs.

The recently completed study investigated the therapeutic efficacy of the Immunotronics™ platform in an extensively used mouse model of heart failure (post-MI remodeling). In the model, treatment with Endonovo’s non-invasive electroceutical two or three times per day resulted in considerably increased cardiac function and reduced ventricular remodeling.

Endonovo Therapeutics, Inc. (ENDV), closed Thursday's trading session at $0.0588, down 2.00%, on 664,699 volume with 40 trades. The average volume for the last 60 days is 1,937,840 and the stock's 52-week low/high is $0.0092/$0.136.

AltiGen Communications, Inc. (ATGN)

OTC Markets and Marketbeat reported on AltiGen Communications, Inc. (ATGN), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

AltiGen Communications, Inc. is a provider of Hosted Skype for Business and Contact Center solutions. The Company is a leading Microsoft Cloud Solutions provider. It delivers fully managed Unified Communications services, combining Hosted Skype for Business, Advanced Cloud PBX, and Innovative Cloud Contact Center applications with seamless integration to Office 365. AltiGen Communications has its corporate office in San Jose, California.

The Company’s unique and feature rich Cloud PBX and Multi-Channel Contact Center solutions natively integrate with Skype for Business and Office 365. This is to deliver business-critical functionalities required by SMBs (Small and Midsize Businesses) and enterprises.

AltiGen’s Cloud Unified Communications solution greatly simplifies deployment and management. This is while enabling SMBs and enterprises to substantially reduce costs and lower total cost of ownership. The Company’s all-software solution provides businesses the flexibility to deploy on-premises, in the Cloud, or in a hybrid environment.

AltiGen’s MaxUC is an innovative new Unified Communications solution. It combines the Company’s MaxCS IP PBX with Microsoft’s Skype for Business.

Additionally, the Company has its MaxCS SIP Trunk. The SIP Trunk Service is an enterprise grade VoIP service optimized for AltiGen Communications solutions.

The Company has its MaxACD Cloud. MaxACD enhances Skype for Business and Office 365 with Cloud-based Automated Multimedia Routing and Queuing capabilities to address the Enterprise “Line of Business” requirements for Internal or External customer requests.

Furthermore, AltiGen Communications has its Enterprise Cloud PBX. This is a complete Cloud-based enterprise-wide PBX and Contact Center solution for Office 365, based on AltiGen’s Hosted Skype for Business, integrated with its MaxACD advanced communications application set.

Fundamentally, the design of the Company’s solutions is for high reliability, user-friendliness, and seamless integration to Microsoft infrastructure technologies. AltiGen’s solutions are built on a scalable, open standards platform.

This past September, AltiGen Communications announced that its MaxCS Softswitch IP-PBX, and Contact Center solution was successfully deployed on-premises at Digistream Investigations. The solution was positioned and ultimately sold to Digistream by way of Altigen partner, Capture Technologies of Oakland, California.

Digistream Investigations is a California headquartered surveillance enterprise. The AltiGen MaxCS Softswitch was installed across Digistream Investigations’ 8 branch offices.

Last month, Altigen Communications announced its financial results for Q4 and fiscal year ended September 30, 2017. For Q4 2017, Total revenue rose 5 percent to $2.1 million. Net income was $212,000 GAAP (Generally Accepted Accounting Principles); $216,000 non-GAAP. Operation expenses decreased $651,000, or 29 percent versus Q4 fiscal 2016.

AltiGen Communications, Inc. (ATGN), closed Thursday's trading session at $0.365, down 1.35%, on 31,100 volume with 10 trades. The average volume for the last 60 days is 18,986 and the stock's 52-week low/high is $0.14/$0.37.

Trans World Corp. (TWOC)

Zacks, Wall Street Resources, Marketbeat, Investor-Advantage, and SmallCapVoice reported earlier on Trans World Corp. (TWOC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Trans World Corp. is a foremost owner and operator of casinos and hotels in Europe. The Company, along with its subsidiaries, acquires, develops, and manages casino operations and small-to-mid-size four-star hotels in Europe. Established in 1993, Trans World is headquartered in New York, New York. The Company lists on the OTCQB.

Trans World operates via two segments, Casino and Hotel. It owns and operates casinos and a hotel in the Czech Republic along the German and Austrian borders.

Regarding the Company’s Hotel division, Trans World is planning the development of several hotels. These will be located on or near the sites of the ACC casinos. The first of these hotels, Hotel Savannah, was completed in early 2009. It is next to the Route 59 Casino.

Trans World’s second property is the renovated Hotel Columbus. It was acquired in September of 2014. It is in Seligenstadt, about 25 kilometers from Frankfurt, Germany.

The Company’s third property is the Hotel Freizeit Auefeld. It was acquired in June of 2015. Hotel Freizeit Auefeld is in Hann. Münden, Germany.

Trans World announced in December 2016 that, on December 21, 2016, it acquired, through its subsidiary Trans World Hotels Germany GmbH (TWHG), the Lindner Sport & Aktivhotel Kranichhöhe (Lindner Hotel). This is a business and recreational hotel property in Much, Germany, approximately 19 miles northeast of Bonn.

The Company operates the hotel under its Trans World Hotels (TWH) brand. Trans World planned renovations to upgrade the property to four-stars from its three-star rating. It renamed the property “Hotel Kranichhöhe”.

Trans World announced earlier this year that on March 1, 2017, by way of its subsidiaries, Trans World Hotels & Entertainment a.s. (TWH&E) and TWHG, it purchased the ground lease rights to a four-star business hotel located on the banks of the Danube River in Linz, Austria. The hotel is of particular interest to Trans World because of its geographic location near the center of Linz and its upside potential.

Pertaining to its Casino division, Trans World created the brand name of American Chance Casinos (ACC). Each unit offers an array of table games and state-of-the-art, popular slot machines.

The Company’s casinos include the Ceska Kubice Casino; Casino Route 55, and Casino Route 59. The Ceska Kubice Casino, on the Czech-German border presently has 14 gaming tables including Roulette and Blackjack, 10 automatic roulette terminals, as well as 118 slot machines.

The Casino Route 55, in Dolni Dvoriste, is on the Czech-Austrian border. This casino currently offers 22 gaming tables, 16 automatic roulette terminals, and 190 slot machines.

The Casino Route 59 is roughly 45 minutes north of Vienna near Znojmo. It features a new slot bar and expanded slot area. The casino includes 24 gaming tables, 16 automatic roulette terminals, and 190 slot machines.

Trans World Corp. (TWOC), closed Thursday's trading session at $3.90, down 2.50%, on 200 volume with 1 trade. The average volume for the last 60 days is 1,404 and the stock's 52-week low/high is $3.35/$7.25.

Drone Aviation Holding Corp. (DRNE)

The Observer, OTC Markets Group, PennyStocks24, RedChip, SmallCapVoice and Flagler Financial Group reported previously on Drone Aviation Holding Corp. (DRNE), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Drone Aviation Holding Corp. is a developer and manufacturer of quickly deployable aerial platforms - specialized lighter-than-air aerostats and tethered drones. The Company operates in the Aerospace/Defense Products & Services industry in the Industrial Goods sector. Established in April 2014, Drone Aviation Holding is based in Jacksonville, Florida.

Drone Aviation owns and operates Florida-based Lighter Than Air Systems Corp. (LTAS). LTAS is a developer and supplier of innovative and specialized aerial solutions to the U.S. Government, State municipalities, and commercial entities.

Drone systems are designed and developed in-house employing proprietary technologies and processes. These result in compact, quickly deployable aerostat solutions and mast based systems. Drone systems, utilizing a unique tethering capability, operate in the National Airspace within Federal Aviation Administration (FAA) guidelines for safe operations.

Utilizing a patented tether system, the design of Drone Aviation’s products is to provide prolonged operational duration capabilities combined with improved reliability, inventively fulfilling vital requirements in military, law enforcement, commercial, as well as industrial applications.

Regarding Technology, the Company’s RAPTOR Flight Control System consists of the Georgia Institute of Technology’s GUST autopilot, and the DAC developed GCS. DAC systems have commercial applications ranging from energy infrastructure surveys and security to military missions. This includes communications relay, SIGINT, force protection, as well as convoy escort.

Concerning MISR (Mobile Intelligence, Surveillance, And Reconnaissance) - Mobile ISR, this vehicle provides cost effective situational awareness wherever it is required over even the roughest terrain. It was developed to support Military, Law Enforcement, and Border Patrol.

Regarding Drones, the Company’s Watt is suitable for commercial operators. It necessities only 10-minutes setup and launch. It has a web browser-based GCS and active tether tension management. Drone Aviation’s Bolt is an innovative platform for challenging requirements. It is quiet and military-grade, with a low cost per flight hour. Bolt can fly in harsh conditions.

Drone Aviation’s products also include the Winch Aerostat Small Platform (WASP). This is a mobile, tactical-sized aerostat. It can carry an array of payloads in support of military operations. Typical applications include network communications and intelligence, surveillance, and reconnaissance.

Drone Aviation has introduced FUSE, its automated smart winch tethering system designed to meet the distinctive specifications for DJI Inspire drones. The FUSE Tether System (utilizing a new patent-pending power pack) maximizes drone use for Inspire 1 and Inspire 2 owners.

Recently, Drone Aviation announced that it received an order for its recently upgraded, multi-mission capable tactical Winch Aerostat Small Platform (WASP) from an existing U.S. Department of Defense (DoD) customer. The solider-operated WASP features support for advanced ISR (Intelligence, Surveillance and Reconnaissance) equipment. This includes the simultaneous use of communications and daylight and thermal payloads. These are capabilities sought by the DoD customer following the in-theater use of prior WASP systems.

Drone Aviation Holding Corp. (DRNE), closed Thursday's trading session at $0.96, down 4.92%, on 18,709 volume with 32 trades. The average volume for the last 60 days is 16,753 and the stock's 52-week low/high is $0.66/$3.0999.

MYM Nutraceuticals, Inc. (MYMMF)

OTC Markets, Barchart, Stockhouse, MarketWatch, InvestorsHub, Investing, and Market News Updates reported on MYM Nutraceuticals, Inc. (MYMMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, MYM Nutraceuticals, Inc. concentrates on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. The Company is looking to acquire complementary businesses and assets in the technology, nutraceuticals, as well as CBD sectors. MYM is the sole owner of CBD brands HempMed, Joshua Tree, and Dr. Furbaby. MYM Nutraceuticals has its corporate office in Vancouver, British Columbia.

Joshua Tree is targeted for the mainstream health market. Dr. Furbaby is the Company’s CBD line of products specifically for pets. HempMed is targeted at the dispensary market.

At present, MYM Nutraceuticals is constructing three large-scale production facilities in Canada and Australia. These are the Weedon Project; the Laval Project; and the Northern Rivers Project. Upon completion, the total amount of greenhouse growing space will surpass 2.7 million square feet.

The Weedon Project is in Weedon, Quebec. The Project will include a cannabis museum and a cannabis university for industry training. The Weedon Project has 1.5 million sq. ft. of greenhouse.

The Laval Project facility (Laval, Quebec) is 10,000 sq. ft. It will undergo expansion to 26,000 sq. ft. by 2019. The estimation is that the Laval Project will generate sales of $20 million by 2019.

The Northern Rivers Project (Casino, New South Wales, Australia) is a 1.2 million sq. ft. greenhouse project. The first crop is expected to be planted in Q4 2018. The Northern Rivers Project facility is believed to be the Southern Hemisphere's largest purpose-built greenhouse, designed specifically to produce medical-grade cannabis.

Furthermore, MYM Nutraceuticals has its MJT Manufacturing Project (Toronto, Ontario). The 5,000 sq. ft. production facility is a GMP certified, state-of-the-art extraction lab and production facility dedicated to industrial hemp processing (CBD).

The MYM Australia Project has filed for a Medical Research License in collaboration with Western Sydney University. MYM Nutraceuticals announced this week that PUF Ventures Australia (PVA) filed an application with the Australian Office of Drug Control for a medicinal cannabis license and a cannabis research license in collaboration with The National Institute of Complementary Medicine (NICM). NICM is an Australian Health Research Institute based at Western Sydney University in New South Wales.

MYM Nutraceuticals, Inc. (MYMMF), closed Thursday's trading session at $1.9901, down 5.10%, on 778,504 volume with 534 trades. The average volume for the last 60 days is 515,543 and the stock's 52-week low/high is $0.1296/$2.35.

Sun Pacific Holding Corp. (SNPW)

Zacks, Marketwired, and investorx.ca reported on Sun Pacific Holding Corp. (SNPW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sun Pacific Holding Corp. works to protect the environment with smart green technology. The Company’s subsidiaries include Sun Pacific Power Corp, Street Smart Outdoor Corp, Bella Electrical LLC, National Mechanical Corp, and Sun Pacific Security Corp. Sun Pacific Holding has its corporate headquarters in Manalapan, New Jersey. The Company’s shares trade on the OTC Markets Group’s OTCQB.

In 2016, Company subsidiary, Sun Pacific Power, obtained final design of its Smart Solar Bus Shelter. It commenced deploying it in Sayreville and Howell, New Jersey. The Smart Solar Bus Shelter provides LED lighting for increased visibility and security and also other technological additions not formerly available.

Sun Pacific Power builds next generation solar panels and lighting products made chiefly in the United States. Sun Pacific Power has eight global manufacturing and assembly locations. This includes five in the USA.

Sun Pacific Holding’s subsidiary, Sun Pacific Security, offers customers the latest in security automation systems. This subsidiary enables one to view secure, live and recorded video of their property at any time on their computer, smartphone or tablet.

Recently, Sun Pacific Holding announced that Street Smart Outdoor, its wholly-owned subsidiary, contracted with the State of Rhode Island Transportation Authority. Mr. Nicholas Campanella, Sun Pacific Holding’s Chief Executive Officer, said, "Street Smart Outdoor Corp. has formally signed a ten year contract with the state of Rhode Island Transportation Authority to manage and sell advertising space on over 700 bus shelter faces which serve the local residents of Rhode Island."

In late November, Sun Pacific Holding announced the start of Sun Pacific Power’s contract with the city of Tallahassee. This involves the start of the installation and maintenance of Solar Powered Bus Shelters and Transit Amenities at hundreds of locations throughout Tallahassee, Florida.

The contract is with Star Metro. Star is the transportation authority in the State of Florida’s capital city Tallahassee. Sun Pacific is to provide street furniture and other transit amenities. This includes its solar powered Smart Shelters and benches throughout the city of Tallahassee, fixed routes on the campuses of Florida State University and Florida A&M University, and its unincorporated areas.

This week, Sun Pacific Holding announced its partnership with CrowdfundX, which is a FinTech marketing firm and developer of Dara, a semi-autonomous machine, which empowers public and private companies to streamline retail investor acquisition.

Sun Pacific Holding has engaged CrowdfundX in a 6-month contract. CrowdfundX takes advantage of a combination of Artificial Intelligence (AI) and digital marketing to help issuers acquire retail investors and shareholders at scale.

Sun Pacific Holding Corp. (SNPW), closed Thursday's trading session at $0.70, down 4.11%, on 48,194 volume with 52 trades. The average volume for the last 60 days is 21,784 and the stock's 52-week low/high is $0.045/$2.25.

Liquidmetal® Technologies, Inc. (LQMT)

Marketbeat, Jason Bond, Promotion Stock Secrets, Penny Pro, Winston Small Cap, Wall Street Mover, Greenbackers, SmallCapVoice, PennyStocks24, Pennybuster, SuperNova Elite, Wealth Daily, PennyStocks Forever, and Penny Stocks VIP reported earlier on Liquidmetal® Technologies, Inc. (LQMT), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Liquidmetal® Technologies, Inc. is the leading developer of bulk alloys that use the performance advantages that amorphous alloy technology provides. Amorphous alloys are innovative materials distinguished by their ability to retain a random structure when they solidify. This is versus the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal® Technologies is based in Rancho Santa Margarita, California, where it also has its Manufacturing Center of Excellence.

Liquidmetal has two to three times the strength of titanium and stainless steel. It undergoes processing similar to plastics on the Company's proprietary Liquidmetal molding machines. Liquidmetal Technologies’ class of patented alloys and processes form the underpinning of high performance materials utilized in a wide array of medical, military, consumer, and industrial and sporting goods products.

The Company is the first enterprise to produce amorphous alloys in commercially viable bulk form. This is enabling critical improvements in products across a broad spectrum of industries.

Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Liquidmetal® Technologies’ alloys are, in numerous cases, stronger, harder, more elastic, and more wear and corrosion resistant than typically used high-performance alloys.

The Company’s "bulk" amorphous alloys possess advantages usually associated with plastics. These include the ability to undergo molding into precision, complex, and highly finished products. Liquidmetal® Technologies controls the Intellectual Property (IP) rights with over 70 U.S. patents.

Liquidmetal® Technologies and the University of Southern California’s M.C. Gill Composites Center are working together to develop an advanced manufacturing process to produce large-scale amorphous metal and fiber laminate sheets for space applications.

This past August, Liquidmetal® Technologies announced that it elected Mr. Tony Chung as a Director of the Company. As a result, Mr. Chung resigned as Chief Financial Officer (CFO) of Liquidmetal® Technologies. Mr. Bryce Van, former Corporate Controller, was appointed as Vice President of Finance. Mr. Van will serve as the Company’s principal financial and accounting officer.

Mr. Chung served as Liquidmetal Technologies’ CFO for almost a decade. During this time, he served a vital role in ensuring that the Company had sufficient funding for operations. He helped lead Liquidmetal® Technologies to fulfill its vision as the leader of amorphous alloy technology.

Liquidmetal® Technologies, Inc. (LQMT), closed Thursday's trading session at $0.23, down 2.50%, on 2,730,073 volume with 314 trades. The average volume for the last 60 days is 3,057,981 and the stock's 52-week low/high is $0.181/$0.44.


The QualityStocks
Company Corner


Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.10, up 37.93%, on 50,907,065 volume with 4,097 trades. The stock’s average daily volume over the past 60 days is 5,865,936, and its 52-week low/high is $0.009/$0.0864.

Global Payout, Inc. (GOHE), is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”) has secured a definitive Referral Partnership Agreement with GreenRush Group, Inc. (“greenRush”). This agreement will provide MTRAC with a direct source of revenue from the referral of cannabis-related businesses who secure a contract with greenRush for the use of their e-commerce payment platform, and Green Label Platform.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

MoneyTrac Technology, Inc. Secures Revenue Opportunity with Definitive Referral and Consultant Partnership Agreement with GreenRush Group, Inc.

Bitcoin’s Rise Solidifies the Intersection of Cannabis and Cryptocurrency

MoneyTrac Technology, Inc.’s PotSaver to Create Effective Networking and Marketing Platform for Cannabis Businesses with Launch

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.08, up 29.34%, on 1,057,880 volume with 837 trades. The stock’s average daily volume over the past 60 days is 237,290 and its 52-week low/high is $0.1999/$1.01.

NetworkNewsWire Editorial Coverage: Merger and acquisition (M&A) activity in the cannabis industry is heating up, and market analysts point to several important factors contributing to increased activity. Profit is always a central issue, and as the founders of companies established years ago seek attractive exit strategies, new players are considering ways to enter the field in a profitable way. The rapid evolution of technology and its increasing application also serve as  catalysts for M&A, as larger companies pursue opportunities that are positioned for current or near-term commercial availability. Such expertise and assets developed by smaller brands could potentially turn them into attractive targets for M&A activity. Lexaria Bioscience Corp. (OTCQB: LXRP) (LXRP Profile) is one such potential target due to its proprietary technology for improved taste, rapidity and delivery of bioactive compounds, including cannabinoids.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Merger and Acquisition Activity is Heating Up in the Cannabis Industry

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Offers a Sweet Escape for Cannabis Users without Smoking or Sweeteners

Lexaria Bioscience Files Innovative New Patent Application

Tapinator, Inc. (TAPM)

The QualityStocks Daily Newsletter would like to spotlight Tapinator, Inc. (TAPM). Today, Tapinator, Inc. closed trading at $0.165, off by 2.65%, on 90,490 volume with 26 trades. The stock’s average daily volume over the past 60 days is 87,523 and its 52-week low/high is $0.0711/$0.2419.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Tapinator, Inc. (OTCQB:TAPM), a client of NNW and a leading developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The publication, titled, “Mobile Gaming Acquisitions on Pace to Boom in 2018,” reviews mergers and acquisitions in the mobile gaming market and the operations of key players in the industry. To view the full publication, visit: https://www.networknewswire.com/mobile-gaming-acquisitions-pace-boom-2018

Tapinator, Inc. (TAPM) is a developer and publisher of mobile games on the iOS, Google Play and Amazon platforms. The Company's portfolio includes over 300 mobile gaming titles generating hundreds of thousands of daily player downloads that provide predictable and attractive returns through the sale of branded advertisements and consumer app store transactions. Tapinator, based in New York and with product development teams located throughout the world, was founded in 2013 by a visionary team that has been building mobile games and applications since 2007 and has achieved multiple successful exits.

Tapinator's business strategy includes the creation of a select number of best-in-class Full-Featured Games, such as ROCKY™ and Solitaire Dash, which provide game players with more in-depth, unique content that supports long-term retention and generates higher investment returns. The Full-Featured Games model creates the potential for sustainable $100+ million franchise-type games that have product lifespans of at least five years. Tapinator uses a proprietary set of dynamic development and marketing processes factored upon gaming category, estimated player retention and projected player profitability.

Recent successful launches of two new Full-Featured titles – Big Sport Fishing 2017 and Dice Mage 2 – were recognized on the Apple iOS platform as "New Games We Love." During the game's first seven days after global release, Big Sport Fishing 2017 received well over 520,000 player downloads. Four new titles, ColorFill, Divide & Conquer, Shadowborne and Fusion Heroes, are in the pipeline for release in Q4 2017 and Q1 2018 as well. The formula for these game combines proven gameplay elements with best-in-class monetization systems, supplemented by Tapinator's strong creative team of developers, strategists and product specialists. The company's Rapid-Launch Games division also saw increasing player interest recently with the launch of Fidget Spinner Superhero and Scary Shark Evolution 3D.

Tapinator's diversified revenue sources includes 54 percent from advertising placed within its mobile games and 46 percent from consumer app store purchases. The Company limits advertising placements to between game levels and also runs rewarded video ad units that are tied directly into the game's currency. Tapinator's portfolio includes more than 300 active titles, with no single game accounting for more than 25 percent of total revenues during the first half of 2017.

As Tapinator looks toward the future, opportunities in Virtual Reality (VR) and Augmented Reality (AR) show great promise. The company has released several prototype VR games to gather data before pursuing a more significant VR product. Recent market reports suggest that the VR industry will hit $30 billion by 2020 and the AR industry will surpass that with a projected $120 billion. Tapinator also plans to pursue publishing transactions that leverage its network, platform relationships and operational excellence. Significant opportunities for expanding Tapinator's gaming IP to new platforms such as Steam and leading messaging apps are also on the horizon. The company is targeting a 30+ percent annual bookings growth target for 2017-2019. Disclaimer

Tapinator, Inc. Blog

Tapinator, Inc. News:

NetworkNewsWire Announces Publication on M&A in the Mobile Gaming Industry

Mobile Gaming Acquisitions on Pace to Boom in 2018

Tapinator Announces Full-featured Games Pipeline Through Q1 2018

Carl Data Solutions Inc. (CSE:CRL) (FSE:7C5) (OTC:CDTAF)

The QualityStocks Daily Newsletter would like to spotlight Carl Data Solutions Inc. (CDTAF). Today, Carl Data Solutions Inc. closed trading at $0.357, off by 3.51%, on 999,384 volume with 430 trades. The stock’s average daily volume over the past 60 days is 19,832 and its 52-week low/high is $0.2015/$0.4002.

Carl Data Solutions Inc. (CSE:CRL, FSE:7C5, OTC:CDTAF) (the "Company"), has entered into a letter of intent (the "Letter of Intent") to acquire cryptocurrency mining hardware from Connected Fintech Inc. ("Connected") and partner with Connected with respect to the joint development of a first of its kind IIoT BlockChain technology for integration into the Carl Data's machine learning, predictive analytics and operational metrics for cryptocurrency mining hardware.

Carl Data Solutions Inc. (CSE: CRL) (FSE: 7C5) (OTC: CDTAF), a developer of Big-Data-as-a-Service ("BDaaS")-based solutions for data integration, business intelligence and Industrial Internet-of-Things ("IIoT") applications, is headquartered in Vancouver, British Columbia, Canada. The company's BDaaS enterprise applications platform provides custom cloud-based collection, storage, monitoring and advanced analysis of any data source of any size or complexity.

Carl Data Solutions provides smart, real-time solutions for industries that routinely face an overload of data. The company's team of dedicated data scientists and application developers build environmental monitoring and modeling technology that collects, connects and manages data to protect industrial and infrastructure assets. As experts in data collection, storage, analytics and reporting, the team is experienced in the complex issues facing governmental and industrial sectors and is well positioned in key IIoT market segments to offer customized solutions.

Among the benefits of CARL's Big Data solutions: turning vast quantities of information into meaningful, actionable insights for any business; gathering data from multiple sources and monitoring in real-time, allowing for better decision making and forecasting; identifying business performance issues or operational efficiencies quickly and accurately for cost and time savings; and, mitigating risks with predictive analytic capabilities to manage unplanned events.

The company's most recent acquisitions include:

  • FlowWorks, a SaaS-based monitoring, data collection, alarming, modeling and reporting system utilized by major clients across North America.
  • abEmbedded Systems Ltd., a Mesh and LoRa advanced telemetry platform using industrial grade custom sensors and data loggers operating in over 250 pump stations across North America.
  • Extend to Social (ETS), a social media application that adds a deep analytics layer that provides clients with valuable insights for new marketing campaigns plus behavioral characteristics for customer service, operations and product development.

Carl Data Solutions provides scalable solutions that integrate public data, Smart IIoT and legacy devices that provides real-time alarming and data analysis. Development of a framework that manages large volumes of diverse types of both structured and unstructured data, stored in an unlimited cloud-based platform that offers advanced analytics features for deeper data insights, provides instant analysis of any inbound data. CARL's applications locate relationships and patterns, which can then predict the probability of specific events, providing valuable insights applicable to any entity dealing with operational issues and regulatory requirements. Both technical and business users are able to quickly and easily understand the impact of environmental events on infrastructure through a comprehensive suite of dashboards, geographic information systems and graphic tools.

The company's predictive analytics, machine learning, and web-based applications can be utilized for waste and storm water management, in the protection of oil and gas pipeline stream crossings, and by hydro-electric dams and toxic tailing ponds, among other industrial uses. The global industrial IoT market alone is expected to reach USD $933.62 billion by 2025, according to a new report by Grand View Research, Inc. (http://nnw.fm/yLBv0). Businesses are seeking new operating models that will increase overall productivity, enhance operational efficiency, improve visibility and reduce complexities of various processes – all of which are targets of Carl's Data Solutions.

An expert management team is at the company core with Greg Johnston leading as its president, CEO and director. Johnston is an experienced technology professional with a proven track record of leadership success within both large multinational corporations and small start-up technology ventures. Disclaimer

Carl Data Solutions Inc. Blog

Carl Data Solutions Inc. News:

Carl Data Solutions Signs LOI for Acquisition of Cryptocurrency Mining Hardware and Partnership for IIoT BlockChain Technology Development

Carl Data Solutions Signs Letter of Intent for Solid Waste Management Pilot

Carl Data Solutions Completes Acquisition of Assets of AB Embedded Systems

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG). Today, Medical Cannabis Payment Solutions closed trading at $0.08, up 11.89%, on 782,669 volume with 106 trades. The stock’s average daily volume over the past 60 days is 439,461, and its 52-week low/high is $0.0161/$0.20.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company's state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company's unique "StateSourced" proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven't been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin's cryptocurrency ($Weed) with Medical Cannabis Payment Solutions' StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

"We've completed our transition from development stage to revenue stage," says Roberts. "We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases."

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry. Disclaimer

Medical Cannabis Payment Solutions Company Blog

Medical Cannabis Payment Solutions News:

Medical Cannabis Payment Solutions to Launch New Website and Portal, Completes Rebrand of its Product Offering

Medical Cannabis Payment Solutions (REFG) is “One to Watch”

Medical Cannabis Payment Solutions (REFG) to Purchase Industry Leading Cryptocurrency, Launch Joint Venture Aimed at Alternative Payment Solution for the Cannabis Industry

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.067, up 19.64%, on 10,974,583 volume with 592 trades. The stock’s average daily volume over the past 60 days is 1,847,788 and its 52-week low/high is $0.002/$0.092.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm and SinglePoint Finalize Plans for Cannabis and Bitcoin Focused Applications and Technology

AppSwarm, Inc. (SWRM) and USA Real Estate Holding Company (USTC) Sign LOI to Launch Bitcoin Mobile Wallet

AppSwarm and SinglePoint Sign LOI to Conduct a Shared Roll-Out of Mobile Applications Specifically Geared to the Cannabis Industry

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.057, up 7.55%, on 48,370 volume with 13 trades. The stock’s average daily volume over the past 60 days is 191,283 and its 52-week low/high is $0.003/$0.33.

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare ® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

Skinvisible Announces Proposed Merger with Quoin Pharmaceuticals

New Skinvisible, Inc. (SKVI) Subsidiary Signs Exclusive License Agreement to Distribute Its Topical Cannabis Products in the USA

Skinvisible, Inc. (SKVI) Engages NetworkNewsWire for Corporate Communications Solutions


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(ICIZF) +350.00%


(SAGE) +70.04%


MarketClub Analysis
(ENTL) +49.84%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251